Tag: marijuana
-
Weed company house cleaning: Bonify loses its LP license but grownups are emerging
“We couldn’t be happier to let registered patients know that they can now buy direct from Bonify, a company that truly puts its customers at the core of everything we do,” said company CEO and President Dalbir Bains, back in June 2018, when the company got its Health Canada cannabis sales license. “With the Canadian…
-
Pure Global Cannabis (PURE.V) is up nearly double in a week – and still dirt cheap
When I write about Pure Global (PURE.V), people get confused because a) they’re always down, and b) they’re not a client company. They should be a running joke, right? Like an Instadose or a Namaste (N.V). Well if you bought in when I did, that’s even truer. It hit the markets on opening day around…
-
The hemp shift: Livewell (LVWL.V), Heritage (CANN.C), Ascent (ASNT.C), Isodiol (ISOL.C) lead the CBD chase
If you want CBD, which is the stuff in cannabis that makes you healthier but that doesn’t get you stoned, hemp has as much of the stuff as commercial cannabis does. But hemp doesn’t attract mind boggling valuations on the public markets. On the TSX, 20k sq ft of licensed cannabis in a greenhouse in…
-
Plus Products (PLUS.C) California edibles deal goes public as TGOD spins off US asset
When I call up a CEO and hear their pitch, I mentally rank where that pitch sits in terms of intelligence, opportunity, trustworthiness, alongside all the pitches I’ve heard before. Like a Top Gear leaderboard, it’s hard to crack that list alongside such all-time greats as CannaRoyalty (CRZ.C), iAnthus (IAN.C), and Green Organic Dutchman (TGOD.T).…
-
Too professional: Pure Global (PURE.V) and the companies discounted because they’re actually building businesses
Had a conversation on the phone with Stephen Pynn, VP of Corporate Devs at Pure Global (PURE.V) this week that got me thinking. Pure has had an up and down run since landing on the public markets in July of this year. It ebbs and flows like the tides, never getting really beat up, but also…
-
Gamechanger: iAnthus (IAN.C) and MPX Bioceutical (MPX.C) to merge, go after MedMen (MMEN.C)
A week ago, US dispensary roll-up play MedMen (MMEN.C) closed an $86m financing and a $99.95m loan to help them complete a $682m deal to buy PharmaCann, which has ten dispensaries and three weed grows. It was big news and propelled MMEN stock, which many deem to be overpriced before the deal, substantially higher still.…
-
It’s Weed Wednesday: Canadian cannabis is legal, but what does it all mean?
If you thought weed stocks were going to run when the new Canadian cannabis laws came in, guess again. Those had been baked into share price for over a year so, if anything, we at Equity.guru expected today to be the stock price yawner it has so far been. But that’s not always going to…
-
Sold out: Which Canadian cannabis brands are winning on day one?
Recreational cannabis is legal in Canada, praise Jesus. But anyone who thought pre-rolls would be falling from the sky on day one is living in a fantasy world. Queues are long, stores are already running out of hot sellers, and online traffic is proving hot with looky-loos. Assuming you can find a store that is…
-
Green Organic Dutchman (TGOD.T) must burn for a few days in order to regrow, bigger and better
A reader asked us a few days ago why The Green Organic Dutchman’s (TGOD.T) stock was plummeting over the last few weeks. It’s a fair question. While we were coming up with an answer, TGOD got its sales license. “We have been perfecting our organic grow methodology in Ancaster and are prepared for the Q1…
-
MedMen (MMEN.C) blows out stock to buy 10 dispensaries, three weed farms in Pharmacann deal
In news that pushed MedMen’s (MMEN.C) share price to new highs, the red shirt crew have announced they’re buying US based Pharmacann LLC for $682 million… or, rather, $682 million of MMEN stock, as of October 9. Mind you, the news drove the company share price up significantly, meaning the actual price now being paid…